Table IV.
Association between CDCA7 expression and clinicopathological characteristics of patients with CRC.
| CDCA7 | ||||
|---|---|---|---|---|
| Clinicopathological characteristics | Number of cases | Low | High | P-value |
| Sex | 0.533 | |||
| Male | 61 | 16 | 45 | |
| Female | 43 | 9 | 34 | |
| Age (years) | 0.369 | |||
| <60 | 58 | 12 | 46 | |
| ≥60 | 46 | 13 | 33 | |
| Tumor size | 0.217 | |||
| <5 cm | 64 | 18 | 46 | |
| ≥5 cm | 40 | 7 | 33 | |
| Invasion depth | 0.002 | |||
| Submucosal | 17 | 9 | 8 | |
| Below the muscle layer | 87 | 16 | 71 | |
| Differentiation | 0.318 | |||
| High | 12 | 3 | 9 | |
| Moderate | 78 | 21 | 57 | |
| Poor | 14 | 1 | 13 | |
| TNM stage | ||||
| I–II | 54 | 20 | 34 | 0.001 |
| III–IV | 50 | 5 | 45 | |
| Lymph node metastasis | 0.038 | |||
| Negative | 65 | 20 | 45 | |
| Positive | 39 | 5 | 34 | |
| Distant metastasis | 0.019 | |||
| Negative | 89 | 25 | 64 | |
| Positive | 15 | 0 | 15 | |
CDCA7, cell division cycle associated protein 7; TNM stage, tumor-node-metastasis.